Amotivational Syndrome

The amotivational syndrome (AMS) describes the psychological phenomenon of reduced performance and drive disorders through indifference to apathy due to low or lack of motivation in people. Other symptoms can also be a lack of drive , adynamia and a lack of purposefulness in behavior . This explains the etymology of the AMS as a lack of motivation ( alpha privativum and motivation).

Symptoms can also be found during and after chronic cannabis abuse , solvent consumption , alcoholism (here with a depression ), depression and schizophrenia . According to the Handbook of Clinical Psychopharmacology , amotivational syndrome is listed as a possible side effect of SSRIs in the treatment of clinical depression. Long-term use of psychoactive substances can be seen as either an aggravating factor or a cause . In the case of addiction-related harm, however, the term is considered out of date and the syndrome is not sufficiently empirically proven. The use of the term “amotivational syndrome” is therefore increasingly being avoided.

The terms late starters or non-starters are occasionally used synonymously for the AMS, especially among young people.

Web links

• Amotivational Syndrome / Amotivational Syndrome at DrugScouts.de
• Does the amotivation syndrome exist? at drugcom.de

Individual evidence

1. ^ Roche Lexicon Medicine , 5th edition, Urban & Fischer , Munich / Jena 2003, ISBN 978-3-437-15156-9 , p. 65.
2. ↑ ^{a b c} Problems and consequential damage caused by cannabis use. In: Techniker Krankenkasse . October 6, 2017. Retrieved April 29, 2019 . 
3. ↑ Amotivational Syndrome. In: www.ihresymptome.de. Retrieved April 25, 2019 . 
4. ↑ Jürgen Margraf ; Pschyrembel Editor: Amotivational Syndrome. In: pschyrembel.de. April 2016, accessed April 29, 2019 . 
5. ↑ Willibald Pschyrembel: Clinical Dictionary , 267th edition, Verlag de Gruyter , Berlin / Boston 2017, ISBN 978-3-11-049497-6 , p. 1757.
6. ^ John Preston, O'Neal John, Talaga Mary: Handbook of Clinical Psychopharmacology for Therapists , 7th. Edition, New Harbinger Publications, 2013, ISBN 1-60882-664-3 , p. 193.
7. ^ Lexicon Medicine , 4th edition, special edition, Naumann & Göbel Verlagsgesellschaft, Cologne without year [2005], ISBN 978-3-625-10768-2 , p. 56.
8. ↑ Amotivational Syndrome. In: www.drogen-wissen.de. February 8, 2019, accessed April 25, 2019 . 
9. ↑ Amotivational Syndrome. In: Gesundheit.de. Retrieved April 29, 2019 . 
10. ^ Eva Hoch, Udo Bonnet , Rainer Thomasius , Florian Ganzer, Ursula Havemann-Reinecke, Ulrich W. Preuss: Risks associated with the non-medicinal use of cannabis . In: Deutsches Ärzteblatt international . tape 112 , no. 16 , April 17, 2015, p. 271–278 , doi : 10.3238 / arztebl.2015.0271 , PMID 25939318 , PMC 4442549 (free full text) - ( online version in German: Risks in the non-medical use of cannabis , PDF [accessed on April 29, 2019] review article).
11. ↑ Jan Dreher : Non-Starters. In: Blog Psychiatry to go. November 6, 2014, accessed April 25, 2019 . 

This article is about a health issue. It is not used for self-diagnosis and does not replace a diagnosis by a doctor. Please note the information on health issues !